MARKET

PRGO

PRGO

Perrigo Company
NYSE

Real-time Quotes | Nasdaq Last Sale

52.89
-0.33
-0.62%
Opening 13:31 08/13 EDT
OPEN
53.12
PREV CLOSE
53.22
HIGH
53.59
LOW
52.87
VOLUME
404.63K
TURNOVER
--
52 WEEK HIGH
63.86
52 WEEK LOW
40.01
MARKET CAP
7.22B
P/E (TTM)
30.22
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 10 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average PRGO stock price target is 56.57 with a high estimate of 64.00 and a low estimate of 53.00.

EPS

PRGO News

More
Perrigo Reports Purchase Of 3 Eastern European OTC Skincare, Hair Loss Treatment Brands From Sanofi, No Terms Disclosed; Brands Are Emolium, Iwostin, Loxon
Benzinga · 2d ago
Perrigo (PRGO) Q2 Earnings Surpass Estimates, Revenues Miss
Perrigo (PRGO) reports decent second-quarter 2020 results. The addition of products following Ranir acquisition boosts sales in the quarter.
Zacks · 08/05 16:37
Perrigo EPS beats by $0.16, misses on revenue
Perrigo (NYSE:PRGO): Q2 Non-GAAP EPS of $1.03 beats by $0.16; GAAP EPS of $0.44 beats by $0.03. Revenue of $1.22B (+6.1% Y/Y) misses by $10M. Press Release
seekingalpha · 08/05 16:08
Perrigo (PRGO) Q2 Earnings Beat Estimates
Perrigo (PRGO) delivered earnings and revenue surprises of 18.39% and -0.69%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/05 12:25
Perrigo Co Q2 Adj. EPS $1.03 Beats $0.88 Estimate, Sales $1.22B Miss $1.24B Estimate
Perrigo Co (NYSE:PRGO) reported quarterly earnings of $1.03 per share which beat the analyst consensus estimate of $0.88 by 17.05 percent. This is a 19.77 percent increase over earnings of $0.86 per share from the same
Benzinga · 08/05 12:00
Perrigo Co shares are trading lower after the company reported worse-than-expected Q2 sales results.
Benzinga · 08/05 11:56
Perrigo Co Q2 Adj. EPS $1.03 Beats $0.88 Estimate, Sales $1.20B Miss $1.24B Estimate
Perrigo Co (NYSE: PRGO) reported quarterly earnings of $1.03 per share which beat the analyst consensus estimate of $0.88 by 17.05 percent.
Benzinga · 08/05 11:07
Perrigo Co Q2 Adj. EPS $1.03 Beats $0.88 Estimate, Sales $1.20B Miss $1.24B Estimate
Perrigo Co (NYSE: PRGO) reported quarterly earnings of $1.03 per share which beat the analyst consensus estimate of $0.88 by 17.05 percent.
Benzinga · 08/05 11:07

Industry

Pharmaceuticals
-1.97%
Pharmaceuticals & Medical Research
-1.26%

Hot Stocks

Symbol
Price
%Change

About PRGO

Perrigo Company PLC (Perrigo) is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company's segments include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx) and Specialty Sciences. It manufactures OTC healthcare products and supplies infant formulas for the store brand market. The CHC segment is focused on the sale of OTC store brand products. The BCH segment develops, manufactures, markets and distributes various European OTC brands. The Rx segment develops, manufactures and markets a portfolio of specialty pharmaceutical prescription drugs. The Specialty Sciences segment consists of assets focused on the treatment of multiple sclerosis, specifically in connection with the drug, Tysabri.
More

Webull offers kinds of Perrigo Company PLC stock information, including NYSE:PRGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRGO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PRGO stock methods without spending real money on the virtual paper trading platform.